Hongxin Deng - Concepedia

Author

Hongxin Deng

Sichuan University ORCID

Also Known As

Deng, H., H DENG, H Deng, H. Deng, H. X. Deng, H.X. Deng, HAIJING DENG, HONGXIN DENG, Hong-Sen Deng, Hong-Xin Deng

194

Publications

4.7K

Citations

H-Index

123

Concepts

All Affiliations

Sichuan University State Key Laboratory of Biotherapy West China Hospital of Sichuan University West China Second University Hospital of Sichuan University Chinese Academy of Medical Sciences & Peking Union Medical College

About

Hongxin Deng is an author at Sichuan University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	38	2.1K
2	Engineering	10	10	401
3	Health Sciences	1	1	128
4	Public Health	1	1	17
5	Allergy	1	1	40

Hongxin Deng

103

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity Wei Wang, Zimin Chen, Shuaiyao Lu, Nature VaccinationVaccine DevelopmentVaccine TargetImmunologyS Protein	2020	836
IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production Xiu Teng, Zhonglan Hu, Xiaoqiong Wei, The Journal of Immunology Cutaneous KeratinocytesImmunologyImmune RegulationImmunologic MechanismInnate Immunity	2014	167
Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis Yuan Wang, Jun‐Li Liu, Qingyuan Jiang, Stem Cells Breast OncologyImmunologyTumor BiologyRegenerative MedicineAngiogenesis	2017	128
A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel Maling Gou, Xingyi Li, Mei Dai, International Journal of Pharmaceutics Biopolymer GelNanomedicineHydrogelsEngineeringDrug Delivery Systems	2008	124
RETRACTED ARTICLE: SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin Lei Dai, Xueliang Cui, Xin Zhang, Nature Communications	2016	123
Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy Gang Shi, Qianmei Yang, Yujing Zhang, Molecular Therapy	2018	111
SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth <i>In Vivo</i> Shuang Zhang, Zhixing Cao, Hongwei Tian, Clinical Cancer Research	2011	101
IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis Junfeng Zhang, Yi Lin, Chunlei Li, The Journal of Immunology Immune RegulationImmunologyDermatologyPsoriatic ArthritisImmune Dysregulation	2016	92
Polyelectrolyte membranes prepared by dynamic self-assembly of poly (4-styrenesulfonic acid-co-maleic acid) sodium salt (PSSMA) for nanofiltration (I) Hongxin Deng, Yanhui Xu, Bao‐Ku Zhu, Journal of Membrane Science Dynamic Self-assemblyChemical EngineeringMembrane FormationEngineeringMembrane Technology	2008	80
<scp>IL</scp>‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells Yuan Wang, Ying Mao, Junfeng Zhang, Journal of Cellular and Molecular Medicine	2017	73

Page 1